Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

826.71 +22.44 (+2.79%)
Streaming Delayed Price Updated: 1:39 PM EDT, Aug 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,431,146
Open 833.62
Bid (Size) 826.03 (1)
Ask (Size) 827.38 (2)
Prev. Close 804.27
Today's Range 820.18 - 840.89
52wk Range 446.89 - 966.10
Shares Outstanding N/A
Dividend Yield 0.55%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Eli Lilly's Popular Weight Loss/Diabetes Drug Tirzepatide Cuts Heart Failure Risk By 38%, Pivotal Phase 3 Study Shows
Eli Lilly's SUMMIT phase 3 trial shows tirzepatide significantly reduces heart failure risk in adults with HFpEF and obesity. Tirzepatide achieved primary and secondary endpoints, including improved... 
Via Benzinga
Pfizer Just Confirmed It's a Dividend Investor's Dream Stock
This big pharma stock gives investors juicy and reliable dividends plus the potential for future growth. 
Via The Motley Fool

Performance

YTD
+39.60%
+39.60%
1 Month
-9.59%
-9.59%
3 Month
+6.43%
+6.43%
6 Month
+28.05%
+28.05%
1 Year
+82.46%
+82.46%

More News

Read More
Pfizer to Buy a GLP-1 Drugmaker? Here's Why You Shouldn't Count on That Happening
Via The Motley Fool
The Top 3 Healthcare Stocks to Buy Now: Summer 2024
Via InvestorPlace
What's Going On With Eli Lilly Today?
Via Benzinga
This Is What Whales Are Betting On Eli Lilly and Co
Via Benzinga
Unpacking the Latest Options Trading Trends in Eli Lilly and Co
Via Benzinga
Is Eli Lilly Stock a Buy?
Via The Motley Fool
3 Biotech Stocks That Could Make Your Summer Unforgettable
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Unlocking the Next 3 Trillion-Dollar Stock Opportunities
Via InvestorPlace
1 Weight Loss Pharma Stock to Buy, and 1 to Consider
Via The Motley Fool
Healthy Profits: 7 Healthcare Stocks to Build a Lifetime of Wealth
Via InvestorPlace
DexCom Stock Plunged Over 40% Last Week. Are Eli Lilly's and Novo Nordisk's Drugs to Blame?
Via The Motley Fool
Eli Lilly’s $123 Billion Market Value Drop: A Strategic Buying Opportunity?
Via Talk Markets
3 Overlooked Stocks Poised for a Breakout Very Soon
Via InvestorPlace
What Will Be the Best Weight Loss Drug Stock of 2030: Eli Lilly, or Novo Nordisk?
Via The Motley Fool
Weight Loss Drug Stocks Just Took a Hit. Should You Buy the Stock That Caused It?
Via The Motley Fool
Attention, Growth Investors: This Biotech Stock Is Crushing Nvidia.
Via The Motley Fool
7 Smart Stocks to Buy BEFORE They Report Q2 Earnings
Via InvestorPlace
Home Depot Stock Turned $1,000 Into $17.5 Million, and One of Its Founders Just Revealed His Investing Secrets to Achieve Generational Wealth
Via The Motley Fool
Week In Review: Nanjing Triastek Partners With BioNTech In A $1.2 Billion Drug Development Deal
Via Talk Markets
Novo Nordisk's Next-Gen Diabetes Candidate Could Challenge Ozempic -- Is the Stock a Buy?
Via The Motley Fool
These 2 Growth Stocks Are Set to Soar This Summer and Beyond
Via The Motley Fool
Bull Market Buys: 2 Growth Stocks to Own for the Long Run
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.